HEADER TRANSPORT PROTEIN 01-NOV-98 1BZK TITLE STRUCTURAL STUDIES ON THE EFFECTS OF THE DELETION IN THE RED CELL TITLE 2 ANION EXCHANGER (BAND3, AE1) ASSOCIATED WITH SOUTH EAST ASIAN TITLE 3 OVALOCYTOSIS. COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (BAND 3 ANION TRANSPORT PROTEIN); COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL CYTOPLASM/FIRST MEMBRANE SPAN; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: PEPTIDE CORRESPONDS TO THE SECTION R-389 -K-430 IN COMPND 7 HUMAN BAND 3. SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED USING FMOC SOURCE 4 PEPTIDE STRATEGY. THE SEQUENCE OF THE PEPTIDE IS NATURALLY FOUND IN SOURCE 5 THE CYTOPLASM/MEMBRANE RED CELL OF HOMO SAPIENS. KEYWDS HUMAN ERYTHROCYTE ANION TRANSPORTER, TRANSMEMBRANE, SYNTHETIC KEYWDS 2 PEPTIDE, TRANSPORT PROTEIN EXPDTA SOLUTION NMR NUMMDL 21 AUTHOR E.J.CHAMBERS,G.B.BLOOMBERG,S.M.RING,M.J.A.TANNER REVDAT 6 27-DEC-23 1BZK 1 REMARK REVDAT 5 16-FEB-22 1BZK 1 REMARK LINK REVDAT 4 24-FEB-09 1BZK 1 VERSN REVDAT 3 01-APR-03 1BZK 1 JRNL REVDAT 2 26-APR-00 1BZK 3 HEADER COMPND REMARK SEQRES REVDAT 2 2 3 HET HELIX HETATM ATOM REVDAT 1 01-JUN-99 1BZK 0 JRNL AUTH E.J.CHAMBERS,G.B.BLOOMBERG,S.M.RING,M.J.TANNER JRNL TITL STRUCTURAL STUDIES ON THE EFFECTS OF THE DELETION IN THE RED JRNL TITL 2 CELL ANION EXCHANGER (BAND 3, AE1) ASSOCIATED WITH SOUTH JRNL TITL 3 EAST ASIAN OVALOCYTOSIS. JRNL REF J.MOL.BIOL. V. 285 1289 1999 JRNL REFN ISSN 0022-2836 JRNL PMID 9887277 JRNL DOI 10.1006/JMBI.1998.2392 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.J.CHAMBERS,G.B.BLOOMBERG,S.M.RING,M.J.A.TANNER REMARK 1 TITL STUDIES ON THE STRUCTURE OF A TRANSMEMBRANE REGION AND A REMARK 1 TITL 2 CYTOPLASMIC LOOP OF THE HUMAN RED CELL ANION EXCHANGER REMARK 1 TITL 3 (BAND3, AE1) REMARK 1 REF BIOCHEM.SOC.TRANS. V. 26 516 1998 REMARK 1 REFN ISSN 0300-5127 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN THE REMARK 3 EUR. J. BIOCHEM. 1994, V221, 445-454. REMARK 4 REMARK 4 1BZK COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-MAY-99. REMARK 100 THE DEPOSITION ID IS D_1000000005. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 3.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NOESY; COSY; HOHAHA; 2D HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : ALPHA 500 REMARK 210 SPECTROMETER MANUFACTURER : JEOL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 21 REMARK 210 CONFORMERS, SELECTION CRITERIA : NO NOE VIOLATIONS GREATER THAN REMARK 210 0.05 NM, NO DIHEDRAL VIOLATIONS REMARK 210 GREATER THAN 5 DEGREES. REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 8 REMARK 210 REMARK 210 REMARK: REMARK 210 THE STRUCTURE WAS DETERMINED USING 2D HOMONUCLEAR AND 2D N-15/H-1 REMARK 210 HETERONUCLEAR NMR SPECTROSCOPY. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 TYR A 3 86.32 -161.55 REMARK 500 1 PRO A 4 -78.68 -87.73 REMARK 500 1 PRO A 16 -69.32 -92.90 REMARK 500 1 ALA A 28 -72.07 -85.57 REMARK 500 1 LEU A 30 24.57 -78.13 REMARK 500 2 TYR A 3 -49.77 164.93 REMARK 500 2 ASP A 12 -66.78 -91.68 REMARK 500 2 SER A 15 63.00 35.49 REMARK 500 2 ILE A 34 -37.89 -29.69 REMARK 500 3 TYR A 3 70.81 -167.02 REMARK 500 3 ASP A 9 -109.77 -90.19 REMARK 500 3 PHE A 14 -79.60 -90.33 REMARK 500 3 PHE A 24 -38.57 -28.72 REMARK 500 4 TYR A 3 59.84 -175.44 REMARK 500 4 PRO A 4 -63.90 -91.89 REMARK 500 4 PRO A 16 -69.52 -92.59 REMARK 500 5 TYR A 3 87.08 37.59 REMARK 500 5 PRO A 4 -71.62 -86.53 REMARK 500 5 ASP A 9 -66.82 -90.68 REMARK 500 5 PHE A 24 -36.08 -32.71 REMARK 500 5 PHE A 27 -29.30 -39.33 REMARK 500 5 ALA A 29 -66.76 -91.62 REMARK 500 5 LEU A 30 36.96 -91.15 REMARK 500 6 ASP A 9 -107.80 -88.88 REMARK 500 6 THR A 11 30.94 -90.26 REMARK 500 6 ASP A 12 -70.06 -74.60 REMARK 500 6 PRO A 16 -66.97 -91.69 REMARK 500 6 PHE A 27 -31.33 -37.07 REMARK 500 6 ALA A 29 -89.38 -91.70 REMARK 500 6 LEU A 39 -172.84 -59.59 REMARK 500 7 TYR A 3 77.73 -154.85 REMARK 500 7 SER A 8 -9.38 -58.11 REMARK 500 7 ASP A 9 -90.16 -53.08 REMARK 500 7 PRO A 16 -65.09 -91.01 REMARK 500 7 LEU A 30 3.71 -66.08 REMARK 500 7 PHE A 36 -94.92 -78.84 REMARK 500 7 LEU A 40 -71.59 -86.77 REMARK 500 8 ALA A 29 -62.08 -91.36 REMARK 500 8 ILE A 34 -75.96 -38.56 REMARK 500 9 TYR A 3 -50.28 169.40 REMARK 500 9 ALA A 13 43.68 -101.14 REMARK 500 9 PHE A 14 -36.18 -34.88 REMARK 500 9 SER A 15 94.29 34.58 REMARK 500 9 LEU A 39 -70.87 -79.19 REMARK 500 9 GLU A 42 -75.57 -86.70 REMARK 500 10 PRO A 4 -88.46 -86.62 REMARK 500 10 ALA A 13 41.62 -105.68 REMARK 500 10 SER A 15 104.75 20.91 REMARK 500 10 ALA A 28 -79.17 -84.62 REMARK 500 10 LEU A 30 8.91 -68.93 REMARK 500 REMARK 500 THIS ENTRY HAS 104 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 1 ARG A 2 0.17 SIDE CHAIN REMARK 500 2 ARG A 2 0.26 SIDE CHAIN REMARK 500 3 ARG A 2 0.28 SIDE CHAIN REMARK 500 4 ARG A 2 0.28 SIDE CHAIN REMARK 500 5 ARG A 2 0.09 SIDE CHAIN REMARK 500 6 ARG A 2 0.24 SIDE CHAIN REMARK 500 7 ARG A 2 0.31 SIDE CHAIN REMARK 500 8 ARG A 2 0.32 SIDE CHAIN REMARK 500 9 ARG A 2 0.29 SIDE CHAIN REMARK 500 10 ARG A 2 0.28 SIDE CHAIN REMARK 500 11 ARG A 2 0.12 SIDE CHAIN REMARK 500 12 ARG A 2 0.23 SIDE CHAIN REMARK 500 13 ARG A 2 0.18 SIDE CHAIN REMARK 500 14 ARG A 2 0.24 SIDE CHAIN REMARK 500 15 ARG A 2 0.19 SIDE CHAIN REMARK 500 16 ARG A 2 0.12 SIDE CHAIN REMARK 500 17 ARG A 2 0.26 SIDE CHAIN REMARK 500 18 ARG A 2 0.32 SIDE CHAIN REMARK 500 19 ARG A 2 0.20 SIDE CHAIN REMARK 500 20 ARG A 2 0.17 SIDE CHAIN REMARK 500 21 ARG A 2 0.26 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 1BZK A 2 43 UNP P02730 B3AT_HUMAN 389 430 SEQRES 1 A 43 ACE ARG TYR PRO TYR TYR LEU SER ASP ILE THR ASP ALA SEQRES 2 A 43 PHE SER PRO GLN VAL LEU ALA ALA VAL ILE PHE ILE TYR SEQRES 3 A 43 PHE ALA ALA LEU SER PRO ALA ILE THR PHE GLY GLY LEU SEQRES 4 A 43 LEU GLY GLU LYS HET ACE A 1 6 HETNAM ACE ACETYL GROUP FORMUL 1 ACE C2 H4 O HELIX 1 1 LEU A 7 ASP A 12 1 6 HELIX 2 2 GLN A 17 ALA A 28 1 12 LINK C ACE A 1 N ARG A 2 1555 1555 1.30 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 HETATM 1 C ACE A 1 26.765 11.973 7.144 1.00 0.00 C HETATM 2 O ACE A 1 25.584 12.201 7.315 1.00 0.00 O HETATM 3 CH3 ACE A 1 27.664 11.537 8.303 1.00 0.00 C HETATM 4 H1 ACE A 1 27.251 10.654 8.768 1.00 0.00 H HETATM 5 H2 ACE A 1 27.724 12.332 9.030 1.00 0.00 H HETATM 6 H3 ACE A 1 28.653 11.317 7.928 1.00 0.00 H